HeimSUNPHARMA • NSE
add
Sun Pharmaceutical Industries Ltd
Við síðustu lokun
1.898,40 ₹
Dagbil
1.915,25 ₹ - 1.959,30 ₹
Árabil
1.068,35 ₹ - 1.959,30 ₹
Markaðsvirði
4,68 bn INR
Meðalmagn
1,87 m.
V/H-hlutf.
44,90
A/V-hlutfall
0,69%
Aðalkauphöll
NSE
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (INR) | jún. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 126,53 ma. | 5,96% |
Rekstrarkostnaður | 69,74 ma. | 7,23% |
Nettótekjur | 28,36 ma. | 40,20% |
Hagnaðarhlutfall | 22,41 | 32,29% |
Hagnaður á hvern hlut | 11,80 | 24,37% |
EBITDA | 35,92 ma. | 10,02% |
Virkt skatthlutfall | 16,18% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (INR) | jún. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 190,90 ma. | 26,17% |
Heildareignir | — | — |
Heildarskuldir | — | — |
Eigið fé alls | 671,06 ma. | — |
Útistandandi hlutabréf | 2,40 ma. | — |
Eiginfjárgengi | 7,15 | — |
Arðsemi eigna | — | — |
Ávöxtun eigin fjár | 10,67% | — |
Peningaflæði
Breyting á handbæru fé
| (INR) | jún. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 28,36 ma. | 40,20% |
Handbært fé frá rekstri | — | — |
Reiðufé frá fjárfestingum | — | — |
Reiðufé frá fjármögnun | — | — |
Breyting á handbæru fé | — | — |
Frjálst peningaflæði | — | — |
Um
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals. Wikipedia
Stofnsett
1983
Höfuðstöðvar
Vefsvæði
Starfsfólk
43.000
